The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 148 | 2022 |
Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients R Koning, P Bastard, JL Casanova, MC Brouwer, D van de Beek Intensive care medicine 47, 704-706, 2021 | 118 | 2021 |
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination TG Caniels, I Bontjer, K van der Straten, M Poniman, JA Burger, ... Science Advances 7 (36), eabj5365, 2021 | 101 | 2021 |
Clinical features and prognostic factors in Covid-19: a prospective cohort study S de Bruin, LD Bos, MA van Roon, AM Tuip-de Boer, AR Schuurman, ... EBioMedicine 67, 2021 | 98 | 2021 |
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination M Grobben, K van der Straten, PJM Brouwer, M Brinkkemper, ... Elife 10, e70330, 2021 | 86 | 2021 |
Muscle abnormalities worsen after post-exertional malaise in long COVID B Appelman, BT Charlton, RP Goulding, TJ Kerkhoff, EA Breedveld, ... Nature communications 15 (1), 1-15, 2024 | 83 | 2024 |
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study MJ van Gils, A Lavell, K van der Straten, B Appelman, I Bontjer, ... PLoS medicine 19 (5), e1003991, 2022 | 78 | 2022 |
Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron K van der Straten, D Guerra, MJ van Gils, I Bontjer, TG Caniels, ... Immunity 55 (9), 1725-1731. e4, 2022 | 75 | 2022 |
Mapping the antigenic diversification of SARS-CoV-2 K van der Straten, D Guerra, MJ van Gils, I Bontjer, TG Caniels, ... MedRxiv, 2022.01. 03.21268582, 2022 | 57 | 2022 |
Efficacy of cognitive-behavioral therapy targeting severe fatigue following coronavirus disease 2019: results of a randomized controlled trial TA Kuut, F Müller, I Csorba, A Braamse, A Aldenkamp, B Appelman, ... Clinical Infectious Diseases 77 (5), 687-695, 2023 | 47 | 2023 |
Development of resistance-associated mutations after sotrovimab administration in high-risk individuals infected with the SARS-CoV-2 Omicron variant E Birnie, JJ Biemond, B Appelman, GJ de Bree, M Jonges, MRA Welkers, ... Jama 328 (11), 1104-1107, 2022 | 45 | 2022 |
Indoleamine 2, 3‐dioxygenase (IDO)‐1 and IDO‐2 activity and severe course of COVID‐19 L Guo, B Schurink, E Roos, EJ Nossent, JW Duitman, APJ Vlaar, ... The Journal of pathology 256 (3), 256-261, 2022 | 34 | 2022 |
Mortality and readmission rates among hospitalized COVID-19 patients with varying stages of chronic kidney disease: a multicenter retrospective cohort B Appelman, JJ Oppelaar, L Broeders, WJ Wiersinga, H Peters-Sengers, ... Scientific reports 12 (1), 2258, 2022 | 30 | 2022 |
The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees J Van Coillie, T Pongracz, J Rahmöller, HJ Chen, CE Geyer, ... EBioMedicine 87, 2023 | 24 | 2023 |
A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern MJ van Gils, HDG van Willigen, E Wynberg, AX Han, K van der Straten, ... Cell Reports Medicine 3 (1), 2022 | 22 | 2022 |
Four SARS-CoV-2 vaccines induce quantitatively different antibody responses against SARS-CoV-2 variants MJ van Gils, AHA Lavell, K van der Straten, B Appelman, I Bontjer, ... | 22 | 2021 |
Differences in incidence, nature of symptoms, and duration of long COVID among hospitalised migrant and non-migrant patients in the Netherlands: a retrospective cohort study FP Chilunga, B Appelman, M van Vugt, K Kalverda, P Smeele, J van Es, ... The Lancet Regional Health–Europe 29, 2023 | 21 | 2023 |
Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination B Appelman, K van der Straten, AHA Lavell, M Schinkel, MA Slim, ... EBioMedicine 72, 2021 | 19 | 2021 |
Prolonged indoleamine 2, 3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infection L Guo, B Appelman, K Mooij-Kalverda, RH Houtkooper, M van Weeghel, ... EBioMedicine 94, 2023 | 13 | 2023 |
Age-related changes in plasma biomarkers and their association with mortality in COVID-19 EHA Michels, B Appelman, J de Brabander, RBE van Amstel, ... European Respiratory Journal 62 (1), 2023 | 11 | 2023 |